about
Genetics of hearing loss in Africans: use of next generation sequencing is the best way forwardBeta-globin gene haplotypes among cameroonians and review of the global distribution: is there a case for a single sickle mutation origin in Africa?Translating biotechnology to knowledge-based innovation, peace, and development? Deploy a Science Peace Corps--an open letter to world leadersReport on the 6th African Society of Human Genetics (AfSHG) Meeting, March 12-15, 2009, Yaounde, CameroonReady to put metadata on the post-2015 development agenda? Linking data publications to responsible innovation and science diplomacy.Perspectives in Genetics and Sickle Cell Disease Prevention in Africa: Beyond the Preliminary Data from CameroonBiomedical research, a tool to address the health issues that affect African populations.SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon.The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival.A call for policy action in sub-Saharan Africa to rethink diagnostics for pregnancy affected by sickle cell disease: differential views of medical doctors, parents and adult patients predict value conflicts in Cameroon.In search of genetic markers for nonsyndromic deafness in Africa: a study in Cameroonians and Black South Africans with the GJB6 and GJA1 candidate genesResearch capacity. Enabling the genomic revolution in Africa.Inauguration of the cameroonian society of human genetics.Treatment for sickle cell disease in Africa: should we invest in haematopoietic stem cell transplantation?Challenges in clinical diagnosis of williams-beuren syndrome in sub-saharan africans: case reports from cameroon.Heterozygous p.Asp50Asn mutation in the GJB2 gene in two Cameroonian patients with keratitis-ichthyosis-deafness (KID) syndrome.Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.A Global Health Diagnostic for Personalized Medicine in Resource-Constrained World Settings: A Simple PCR-RFLP Method for Genotyping CYP2B6 g.15582C>T and Science and Policy Relevance for Optimal Use of Antiretroviral Drug Efavirenz.Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health TransitionAssociation between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic InterventionsPrenatal diagnosis and termination of pregnancy: perspectives of South African parents of children with Down syndrome.Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell diseaseA systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell diseaseProceedings of a Sickle Cell Disease Ontology workshop - Towards the first comprehensive ontology for Sickle Cell DiseaseLow hepatitis B vaccine uptake among surgical residents in CameroonGenomic medicine in Africa: promise, problems and prospects.Ethics of human genetic studies in sub-saharan Africa: the case of Cameroon through a bibliometric analysis.UCT's contribution to medical genetics in Africa - from the past into the future.Psychosocial burden of sickle cell disease on parents with an affected child in Cameroon.Cytochrome P450 pharmacogenetics in African populations: implications for public health.Current needs for human and medical genomics research infrastructure in low and middle income countries.An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine.Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.Would you terminate a pregnancy affected by sickle cell disease? Analysis of views of patients in Cameroon.Aetiology of childhood hearing loss in Cameroon (sub-Saharan Africa).Acceptability of prenatal diagnosis by a sample of parents of sickle cell anemia patients in Cameroon (sub-Saharan Africa).Sickle cell disease: tipping the balance of genomic research to catalyse discoveries in Africa.Psychosocial stressors of sickle cell disease on adult patients in Cameroon.Studies of novel variants associated with Hb F in Sardinians and Tanzanians in sickle cell disease patients from Cameroon.African Lettuce (Launaea taraxacifolia) Displays Possible Anticancer Effects and Herb-Drug Interaction Potential by CYP1A2, CYP2C9, and CYP2C19 Inhibition.
P50
Q26799628-F391BD70-5063-45A0-8194-EAC336F23C28Q26829773-CFDE4127-8DEC-4E82-84CA-E20C0F8129EAQ27003942-D49C2435-9D71-4E73-ADA1-8284E95D9748Q28750169-9D9B5B8B-A555-481A-87E4-B84187D3BEA0Q30062193-5932D44A-AE5E-45DB-BDA3-4E9DBA0FB30CQ30965927-EB49D747-BDB1-4EE7-85BE-F44E9990DA34Q33589357-691760ED-E2E3-4E1A-AC53-95ED13310E55Q33667950-E5BCF707-C106-47ED-9640-CD6DA4FE09DDQ33825794-4D30326A-6720-47E7-8204-9ABB5F8FEDABQ33861110-2BEBB767-FCB9-4540-B972-13D9B18D7EC2Q33861273-0CF851CC-4873-4751-9A93-08DA728966CFQ34068017-27E3D353-A497-4043-BE33-8E295DF044BDQ34321026-C71A70C5-E26B-43CF-ACB5-333654DA2678Q34431739-A1EE4D19-9178-41C3-A2FE-5EB3A2380C47Q34800069-3B953907-1007-42CC-873B-39B73170EB06Q34908608-1486793C-EDB6-4855-AE5C-EAE715432F14Q35131049-56F009BB-33D2-4C9E-A45A-130404B42749Q35802412-03AE019B-9056-4A32-A82D-CE06D41C7AB2Q36105822-8C11FC0C-180F-4946-9FC7-0DB90868B700Q36191670-DC0FF8B2-9142-49C0-A2F6-40FA881899B3Q36511304-2ADCE904-8495-416F-B499-7A76E30AB54EQ36777717-781A9A0C-1F73-4A0A-9972-BD1234EF5119Q36792555-BF4EC007-CF66-4051-B9A6-FA9351B7FFAFQ37014532-73E952AC-47C7-4C7E-8A94-5B4F202CCDF9Q37683841-3EEA7D89-8431-417C-BCC1-3D919E588350Q37690919-D76BCB8B-02FC-46B6-BCC3-C7665B75A920Q37903922-75C89340-6ABE-4BFC-867B-906018EC94CDQ38016293-77EA7585-AD65-4BC9-AF42-D9D7B364109AQ38123725-4FFEB824-3B02-43F6-9293-807E8DD2C020Q38192688-92BCA937-2CB0-4F08-83D2-8E5D2F8D8317Q38383856-4C834306-1442-40EE-A38B-1E352A5FCD1DQ38956275-3420D3EB-C4AF-480B-B1A2-5C9840FE5F0AQ38977617-3BF743B7-7281-44D1-A9FF-6C9D7231EE51Q39372042-C76F76AE-E60E-4D1A-9CD7-FB08AADF586CQ39601676-D358C607-C821-44D6-99F2-8BF971C144A4Q39984106-9811C401-FA8C-4846-A4DE-5266046C3CCFQ40164021-CA5B64D3-BCFC-4D16-81AF-94FFB7A42A60Q40172599-81D4BA4B-4DA5-474B-B392-3315D6B53036Q40458232-8B65E4B6-AF90-4778-A6A9-B2CDB6910EC9Q40539339-25D5273B-C628-4F4F-9374-3084BF1C76E0
P50
description
researcher ORCID ID = 0000-0003-1420-9051
@en
name
Ambroise Wonkam
@ast
Ambroise Wonkam
@en
Ambroise Wonkam
@es
Ambroise Wonkam
@nl
type
label
Ambroise Wonkam
@ast
Ambroise Wonkam
@en
Ambroise Wonkam
@es
Ambroise Wonkam
@nl
prefLabel
Ambroise Wonkam
@ast
Ambroise Wonkam
@en
Ambroise Wonkam
@es
Ambroise Wonkam
@nl
P31
P496
0000-0003-1420-9051